The prenatal intervention of pregnancy complicated with anti-Kell isoimmunization: a review

References

• Lee S. Molecular basis of Kell blood group phenotypes. Vox Sang. 1997;73(1):1–11.
   PubMed Web of Science ®Google Scholar
• Denomme GA. Kell and Kx blood group systems. Immunohematology. 2015;31(1):14–19.
   PubMedGoogle Scholar
• de Haas M, Thurik FF, Koelewijn JM, et al. Haemolytic disease of the fetus and newborn. Vox Sang. 2015;109(2):99–113.
   PubMed Web of Science ®Google Scholar
• Sgro M, Campbell DM, Kandasamy S, et al. Incidence of chronic bilirubin encephalopathy in Canada, 2007–2008. Pediatrics. 2012;130(4):e886–e890.
   PubMed Web of Science ®Google Scholar
• Qureshi H, Massey E, Kirwan D, et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfusion Med. 2014;24(1):8–20.
   PubMed Web of Science ®Google Scholar
• Goldman M, Lane D, Webert K, et al. The prevalence of anti-K in Canadian prenatal patients. Transfusion. 2015;55(6pt2):1486–1491.
   PubMed Web of Science ®Google Scholar
• Hendrickson JE, Tormey CA. Understanding red blood cell alloimmunization triggers. Hematology. 2016;2016(1):446–451.
   PubMed Web of Science ®Google Scholar
• Caine ME, Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol. 1986;154(1):85–90.
   PubMed Web of Science ®Google Scholar
• Grant SR, Kilby MD, Meer L, et al. The outcome of pregnancy in Kell alloimmunisation. BJOG: An Int J O&G. 2000;107(4):481–485.
   PubMed Web of Science ®Google Scholar
• Siransy Bogui L, Dembele B, Sekongo Y, et al. Phenotypic profile of Rh and Kell blood group systems among blood donors in Cote d’Ivoire, West Africa. J Blood Transfus. 2014;2014:309817.
   PubMedGoogle Scholar
• Guelsin GAS, Sell AM, Castilho L, et al. Genetic polymorphisms of Rh, Kell, Duffy and Kidd systems in a population from the State of Paraná, southern Brazil. Rev Bras Hematol Hemoter. 2010;33(1):21–25.
   Google Scholar
• Makroo RN, Bhatia A, Gupta R, et al. Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor population. Indian J Med Res. 2013;137(3):521–526.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zeng R, Chen Q, et al. Genotyping for Kidd, Kell, Duffy, Scianna, and RHCE blood group antigens polymorphisms in Jiangsu Chinese Han. Chin Med J. 2012;125(6):1076–1081.
   PubMed Web of Science ®Google Scholar
• Gassner C, Degenhardt F, Meyer S, et al. Low-frequency blood group antigens in Switzerland. Transfus Med Hemother. 2018;45(4):239–250.
   PubMed Web of Science ®Google Scholar
• Musa RH, Ahmed SA, Hashim H, et al. Red cell phenotyping of blood from donors at the National Blood Center of Malaysia. Asian J Transfus Sci. 2012;6(1):3–9.
   PubMedGoogle Scholar
• Körmöczi GF, Wagner T, Jungbauer C, et al. Genetic diversity of KELnull and KELel: a nationwide Austrian survey. Transfusion. 2007;47(4):703–714.
   PubMed Web of Science ®Google Scholar
• Vaughan JI, Manning M, Warwick RM, et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med. 1998;338(12):798–803.
   PubMed Web of Science ®Google Scholar
• Ahaded A, Brossard Y, Debbia M, et al. Quantitative determination of anti-K (KEL1) IgG and IgG subclasses in the serum of severely alloimmunized pregnant women by ELISA. Transfusion. 2000;40(10):1239–1245.
   PubMed Web of Science ®Google Scholar
• Koelewijn JM, Vrijkotte TGM, Van Der Schoot CE, et al. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion. 2008;48(5):941–952.
   PubMed Web of Science ®Google Scholar
• Kamphuis MM, Lindenburg I, Van Kamp IL, et al. Implementation of routine screening for Kell antibodies: does it improve perinatal survival? Transfusion. 2008;48(5):953–957.
   PubMed Web of Science ®Google Scholar
• Moise KJ. Fetal anemia due to non-rhesus-D red-cell alloimmunization. Semin Fetal Neonat Med. 2008;13(4):207–214.
   PubMed Web of Science ®Google Scholar
• Orlando N, Bianchi M, Valentini CG, et al. Red cell alloantibody screening: comparative analysis of three different technologies. Transfus Med Hemother. 2018;45(3):179–183.
   PubMed Web of Science ®Google Scholar
• Van Wamelen DJ, Klumper FJ, De Haas M, et al. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy. Obstet. Gynecol. 2007;109(5):1093–1098.
   Google Scholar
• Ferro M, Macher HC, Fornés G, et al. Noninvasive prenatal diagnosis by cell-free DNA screening for fetomaternal HPA-1a platelet incompatibility. Transfusion. 2018;58(10):2272–2279.
   PubMed Web of Science ®Google Scholar
• van der Schoot CE, Tax GHM, Rijnders RJP, et al. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev. 2003;17(1):31–44.
   PubMed Web of Science ®Google Scholar
• Cro’ F, Lapucci C, Vicari E, et al. An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens. Am J Reprod Immunol. 2016;76(6):499–503.
   PubMed Web of Science ®Google Scholar
• Fasano RM. Hemolytic disease of the fetus and newborn in the molecular era. Semin Fetal Neonat Med. 2016;21(1):28–34.
   PubMed Web of Science ®Google Scholar
• Li Y, Finning K, Daniels G, et al. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry. Prenat Diagn. 2008;28(3):203–208.
   PubMed Web of Science ®Google Scholar
• Reid ME. Applications and experience with PCR-based assays to predict blood group antigens. Transfus Med Hemother. 2009;36(3):168–178.
   PubMed Web of Science ®Google Scholar
• Liley AW. Liquor amnii analysis in the management of the pregnancy complicated by rhesus sensitization. Am J Obstet Gynecol. 1961;82(6):1359–1370.
   PubMed Web of Science ®Google Scholar
• Queenan JT, Tomai TP, Ural SH, et al. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks’ gestation: a proposal for clinical management. Am J Obstet Gynecol. 1993;168(5):1370–1376.
   PubMed Web of Science ®Google Scholar
• Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity. N Engl J Med. 2000;342(1):9–14.
   PubMed Web of Science ®Google Scholar
• Teixeira JM, Duncan K, Letsky E, et al. Middle cerebral artery peak systolic velocity in the prediction of fetal anemia. Ultrasound Obstet Gynecol. 2000;15(3):205–208.
   PubMed Web of Science ®Google Scholar
• van Dongen H, Klumper F, Sikkel E, et al. Non-invasive tests to predict fetal anemia in Kell-alloimmunized pregnancies. Ultrasound Obstet Gynecol. 2005;25(4):341–345.
   PubMed Web of Science ®Google Scholar
• Rimon E, Peltz R, Gamzu R, et al. Management of Kell isoimmunization – evaluation of a Doppler-guided approach. Ultrasound Obstet Gynecol. 2006;28(6):814–820.
   PubMed Web of Science ®Google Scholar
• Santiago JC, Ramos-Corpas D, Oyonarte S, et al. Current clinical management of anti-Kell alloimmunization in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2008;136(2):151–154.
   PubMed Web of Science ®Google Scholar
• Schumacher B, Moise KJ. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol. 1996;88(1):137–150.
   PubMed Web of Science ®Google Scholar
• Van Kamp IL, Klumper F, Oepkes D, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol. 2005;192(1):171–177.
   PubMed Web of Science ®Google Scholar
• Tiblad E, Kublickas M, Ajne G, et al. Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm. Fetal Diagn Ther. 2011;30(4):266–273.
   PubMed Web of Science ®Google Scholar
• Schonewille H, Klumper F, van de Watering LMG, et al. High additional maternal red cell alloimmunization after rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus. Am J Obstet Gynecol. 2007;196(2):143.e1–143.e6.
   Google Scholar
• Van Kamp IL, Klumper F, Meerman RH, et al. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988–1999. Acta Obstet Gynecol Scand. 2004;83(8):731–737.
   PubMed Web of Science ®Google Scholar
• Babinszki A, Lapinski RH, Berkowitz RL. Prognostic factors and management in pregnancies complicated with severe Kell alloimmunization: experiences of the last 13 years. Amer J Perinatol. 1998;15(12):695–701.
   PubMed Web of Science ®Google Scholar
• McKenna DS, Nagaraja HN, O’Shaughnessy R. Management of pregnancies complicated by anti-Kell isoimmunization. Obstet Gynecol. 1999;93(5 Pt 1):667–673.
   PubMed Web of Science ®Google Scholar
• Walsh CA, Russell N, Mcauliffe FM, et al. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation. Eur J Obstet Gynecol Reprod Biol. 2013;171(2):235–239.
   PubMed Web of Science ®Google Scholar
• Phung TV, Houfflin-Debarge V, Ramdane N, et al. Maternal red blood cell alloimmunization requiring intrauterine transfusion: a comparative study on management and outcome depending on the type of antibody. Transfusion. 2018;58(5):1199–1205.
   PubMed Web of Science ®Google Scholar
• Rath MEA, Smits-Wintjens V, Lindenburg ITM, et al. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease. Vox Sang. 2011;100(3):312–316.
   PubMed Web of Science ®Google Scholar
• Moise KJ, Argoti PS. Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol. 2012;120(5):1132–1139.
   PubMed Web of Science ®Google Scholar
• Stephen J, Cairns LS, Pickford WJ, et al. Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen. Blood. 2012;119(23):5563–5574.
   PubMed Web of Science ®Google Scholar
• Stowell SR, Henry KL, Smith NH, et al. Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model. Blood. 2013;122(8):1494–1504.
   PubMed Web of Science ®Google Scholar